Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of aryl phenylketones and thiazole derivatives. It has the molecular formula C18H17N3O3S and a molecular weight of approximately 355.41 g/mol[1][3][5]. The structure features a thiazole ring substituted with amino and methoxyaniline groups as well as two methoxy-substituted phenyl rings. There are no approved medical indications or clinical trials for this compound; it is considered experimental and not approved by any major regulatory agency[1][4]. No detailed mechanism of action or pharmacological activity has been established in public databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone.